X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (71) 71
adult (56) 56
middle aged (53) 53
female (52) 52
oncology (48) 48
aged (42) 42
male (37) 37
index medicus (27) 27
breast cancer (26) 26
cancer (25) 25
breast neoplasms - drug therapy (20) 20
surveys and questionnaires (20) 20
chemotherapy (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
adolescent (16) 16
follow-up studies (16) 16
risk factors (15) 15
norway (14) 14
prognosis (13) 13
research (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
breast neoplasms - pathology (12) 12
testicular cancer (12) 12
cross-sectional studies (11) 11
prevalence (11) 11
treatment outcome (11) 11
care and treatment (10) 10
depression (10) 10
therapy (10) 10
aged, 80 and over (9) 9
fatigue (9) 9
inflammation (9) 9
neoplasms - therapy (9) 9
norway - epidemiology (9) 9
survivors (9) 9
testicular neoplasms - psychology (9) 9
testicular neoplasms - therapy (9) 9
fluorouracil - administration & dosage (8) 8
health aspects (8) 8
medicine (8) 8
postmenopausal women (8) 8
quality of life (8) 8
quality-of-life (8) 8
survival (8) 8
analysis (7) 7
breast neoplasms - metabolism (7) 7
drug administration schedule (7) 7
medisinske fag: 700 (7) 7
oncology, experimental (7) 7
population (7) 7
time factors (7) 7
tumors (7) 7
vdp (7) 7
animals (6) 6
antineoplastic agents - therapeutic use (6) 6
breast neoplasms - genetics (6) 6
breast neoplasms - mortality (6) 6
cancer patients (6) 6
chemotherapy, adjuvant (6) 6
medical disciplines: 700 (6) 6
methotrexate - administration & dosage (6) 6
neoplasm staging (6) 6
scale (6) 6
survivors - psychology (6) 6
survivors - statistics & numerical data (6) 6
women (6) 6
young adult (6) 6
antineoplastic agents - adverse effects (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
anxiety disorder (5) 5
breast neoplasms - therapy (5) 5
carcinoma (5) 5
chronic fatigue syndrome (5) 5
clinical medical disciplines: 750 (5) 5
combination chemotherapy (5) 5
cyclophosphamide (5) 5
disease (5) 5
erbb-2 protein (5) 5
hospital anxiety (5) 5
klinisk medisinske fag: 750 (5) 5
medical and health sciences (5) 5
medicin och hälsovetenskap (5) 5
medicine, general & internal (5) 5
research article (5) 5
risk (5) 5
studies (5) 5
survival analysis (5) 5
survivor (5) 5
anxiety (4) 4
bile - metabolism (4) 4
body-mass index (4) 4
breast density (4) 4
breast neoplasms - diagnosis (4) 4
breast-cancer risk (4) 4
c-reactive protein (4) 4
cancer survivors (4) 4
cancer therapies (4) 4
cholesterol (4) 4
dose-response relationship, drug (4) 4
drug therapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
Psycho‐Oncology, ISSN 1057-9249, 06/2009, Volume 18, Issue 6, pp. 580 - 588
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2011, Volume 29, Issue 3, pp. 264 - 271
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9555, pp. 29 - 36
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2009, Volume 101, Issue 24, pp. 1682 - 1695
Background Sensory neuropathy (paresthesias), tinnitus, hearing impairment, and Raynaud phenomena are side effects of cisplatin-based chemotherapy used to... 
CISPLATIN-BASED CHEMOTHERAPY | HEARING-LOSS | RISK-FACTORS | ONCOLOGY | EUROPEAN CONSENSUS CONFERENCE | CLINICAL STAGE-I | INDUCED PERIPHERAL NEUROPATHY | COMBINATION CHEMOTHERAPY | QUALITY-OF-LIFE | GERM-CELL-CANCER | MEDICAL-RESEARCH-COUNCIL | Paresthesia - epidemiology | Sensation Disorders - epidemiology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prevalence | Audiometry | Follow-Up Studies | Humans | Middle Aged | Survivors - statistics & numerical data | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cisplatin - administration & dosage | Raynaud Disease - epidemiology | Tinnitus - chemically induced | Adult | Surveys and Questionnaires | Odds Ratio | Paresthesia - chemically induced | Hearing Loss - chemically induced | Severity of Illness Index | Sensation Disorders - chemically induced | Cross-Sectional Studies | Drug Administration Schedule | Seminoma - drug therapy | Hearing Loss - epidemiology | Regression Analysis | Tinnitus - epidemiology | Testicular Neoplasms - drug therapy | Norway - epidemiology | Cisplatin - adverse effects | Raynaud Disease - chemically induced | Aged | Research Design | Cancer survivors | Complications and side effects | Prognosis | Demographic aspects | Raynaud's disease | Testicular cancer | Peripheral nerve diseases | Risk factors | Diseases | Index Medicus
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2017, Volume 3, Issue 1, pp. 35 - 1
[This corrects the article DOI: 10.1038/s41523-017-0015-9.]. 
Breast cancer
Journal Article
Tidsskrift for den Norske Laegeforening, ISSN 0029-2001, 11/2011, Volume 131, Issue 22, pp. 2239 - 2241
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2018, Volume 119, Issue 9, pp. 1144 - 1154
Journal Article